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This work was dedicated to the development of a cutaneous gel formulation 
containing miconazole. We chose to develop this formulation because there is no 
drug product available as a cutaneous hydrogel containing an antifungal drug 
substance, dissolved in a pure aqueous vehicle. We compared the activity of this 
hydrogel containing dissolved miconazole with that of Daktarin cream containing 
miconazole nitrate. Miconazole is well known for its antimycotic activity and is 
practically insoluble in water (< 1.03 µg/ml) 
 
The combining effect of 200 mM lactic acid and 75 mM HP-βCD allowed to solubilize 
17.4 mg/g miconazole. This amount is equivalent to 20 mg/g of miconazole nitrate in 
the Daktarin cream. Hydroxyethylcellulose at a 3% concentration was used as 
gelling agent. The gel is transparent and has a pH value close to 3.5.  
 
A study carried out on 15 volunteers showed that the gel containing cyclodextrins is 
well tolerated when applied on an unbroken skin.  
 
With the aid of corneofungimetry, we compared the ex vivo activity of the gel to that 
of the Daktarin cream. The results were difficult to interpret. Differences were 
observed depending on whether the mycelium growth is expressed in terms of 
surface or density. The study requires to be continued because it is difficult to draw a 
conclusion owing to the restricted number of both volunteers and strains.  
 
On the other hand, a comparative in vivo study carried out on 18 volunteers suffering 
from tinea corporis showed that there was no significant difference between the gel 
and the cream in terms of clinical activity, cosmetic acceptance and side effects.  
 
In conclusion, with the combining aid of lactic acid and HP-βCD, it was possible to 
develop an aqueous gel containing miconazole. Unfortunately, we were not able to 
show an increased activity of this hydrogel containing soluble miconazole. This gel 
has the potential advantage to permit an administration by several routes which 
would be a simplification on an industrial point of view.  
 
 
